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2010-2011 Influenza Season 
Week 46 ending November 20, 2010 
All data are preliminary and may change as more reports are received. 
 
Synopsis: During week 46 (November 14-20, 2010), influenza activity in the United States 
remained relatively low overall, but increased slightly in the Southeast. 
o Of the 2,896 specimens tested by U.S. World Health Organization (WHO) and National 
Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and 
reported to CDC/Influenza Division, 284 (9.8%) were positive for influenza. 
o The proportion of deaths attributed to pneumonia and influenza (P&I) was below the 
epidemic threshold.  
o No influenza-associated pediatric deaths were reported.  
o The proportion of outpatient visits for influenza-like illness (ILI) was 1.4%, which is below the 
national baseline of 2.5%. All 10 regions reported ILI below region-specific baseline levels; 
one state experienced high ILI activity; two states experienced low ILI activity, and 47 states 
experienced minimal ILI activity. 
o The geographic spread of influenza in one state was reported as regional, Puerto Rico and 
seven states reported local activity; the District of Columbia, Guam, the U.S. Virgin Islands, 
and 31 states reported sporadic activity; and 11 states reported no influenza activity. 
 
National and Regional Summary of Select Surveillance Components 
 
Data for current week Data cumulative since October 3, 2010 (Week 40) 
HHS 
Surveillance 
Regions* 
Out-
patient 
ILI† 
% 
positive 
for flu‡ 
Number of  
jurisdictions 
reporting 
regional or 
widespread 
activity§ 
A (H3) 2009 A (H1N1) 
A 
(Subtyping not 
performed) 
B Pediatric Deaths 
Nation Normal 9.8% 1 of 54 257 72 410 555 1 
Region 1 Normal 2.1% 0 of 6 10 2 0 1 0 
Region 2 Normal 3.2% 0 of 4 12 0 21 2 0 
Region 3 Normal 1.8% 0 of 6 16 11 2 1 0 
Region 4 Normal 17.0% 1 of 8 88 16 303 477 0 
Region 5 Normal 2.1% 0 of 6 23 4 1 0 0 
Region 6 Normal 2.8% 0 of 5 20 1 35 26 1 
Region 7 Normal 0.6% 0 of 4 2 1 2 2 0 
Region 8 Normal 4.1% 0 of 6 42 12 31 4 0 
Region 9 Normal 3.7% 0 of 5 37 25 14 38 0 
Region 10 Normal 1.6% 0 of 4 7 0 1 4 0 
 
*HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, U.S. Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, 
SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; 
and Region 10: AK, ID, OR, WA). 
† Elevated means the % of visits for ILI is at or above the national or region-specific baseline. 
‡ National data are for current week; regional data are for the most recent three weeks. 
§ Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. 
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U.S. Virologic Surveillance: WHO and NREVSS collaborating laboratories located in all 50 states 
and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and 
the number positive by influenza type and subtype. The results of tests performed during the 
current week are summarized in the table below. 
 
 Week 46 
No. of specimens tested 2,896 
No. of positive specimens (%) 284 (9.8%) 
Positive specimens by type/subtype  
Influenza A 115 (40.5%) 
          A (2009 H1N1)   9 (7.8%)            
          A (subtyping not performed)          85 (73.9%) 
          A (H3)                21 (18.3%)    
Influenza B 169 (59.5%) 
 
The District of Columbia and forty-two states from all 10 surveillance regions have reported 
laboratory-confirmed influenza this season.  Region 4 in the Southeastern United States has 
accounted for 884 (68.3%) of all 1,294 reported influenza viruses this season, including 477 
(85.9%) of the 555 influenza B viruses. 
 
Influenza Positive Tests Reported to CDC by U.S. WHO/NREVSS 
Collaborating Laboratories, National Summary, 2010-11 Season 
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Aggregate Hospitalization and Death Reporting Activity (AHDRA): This system tracks weekly 
counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was 
implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA 
surveillance during the 2010-11 season is being continued on a voluntary basis and 11 jurisdictions 
reported during week 46. From October 3-November 20, 2010, 216 laboratory-confirmed influenza 
associated hospitalizations and four laboratory-confirmed influenza associated deaths were 
reported to CDC. 
  
Weekly Laboratory-Confirmed Influenza-Associated Hospitalizations and 
Deaths, National Summary, 2010-11 Season 
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Antigenic Characterization:  CDC has antigenically characterized 13 influenza viruses [four 2009 
influenza A (H1N1) viruses, three influenza A (H3N2) viruses, and six influenza B virus] collected by 
U.S. laboratories since October 1, 2010. 
 
2009 Influenza A (H1N1) [4] 
• All four were characterized as A/California/7/2009-like, the influenza A (H1N1) 
component of the 2010-11 influenza vaccine for the Northern Hemisphere. 
 
Influenza A (H3N2) [3] 
• All three were characterized as A/Perth/16/2009-like, the influenza A (H3N2) 
component of the 2010-11 influenza vaccine for the Northern Hemisphere. 
 
Influenza B [6] 
• All six viruses belong to the B/Victoria lineage of viruses and were characterized as 
B/Brisbane/60/2008-like, the recommended influenza B component for the 2010-11 
Northern Hemisphere influenza vaccine. 
Antiviral Resistance: Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B 
virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at 
CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a 
single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance 
(H275Y). The data summarized below combine the results of both test methods and includes 
samples that were tested as part of routine surveillance purposes; it does not include diagnostic 
testing specifically done because of clinical suspicion of antiviral resistance. 
High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 
influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B 
viruses) circulating globally. As a result of the sustained high levels of resistance, data from 
adamantane resistance testing are not presented weekly in the table below.     
Neuraminidase Inhibitor Resistance Testing Results  
on Samples Collected Since October 1, 2010. 
 
Viruses 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Viruses 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Oseltamivir Zanamivir 
Seasonal 
Influenza A 
(H1N1) 
0 0 (0.0) 0 0 (0.0) 
Influenza A 
(H3N2) 7 0 (0.0) 7 0 (0.0) 
Influenza B 8 0 (0.0) 8 0 (0.0) 
2009 
Influenza A 
(H1N1) 
7 0 (0.0) 4 0 (0.0) 
 
To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of 
the need to continue hand and cough hygiene measures for the duration of any symptoms of 
influenza, even while taking antiviral medications. Additional information on antiviral 
recommendations for treatment and chemoprophylaxis of influenza virus infection is available at 
http://www.cdc.gov/flu/antivirals/index.htm.    
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Pneumonia and Influenza (P&I) Mortality Surveillance: During week 46, 6.4% of all deaths 
reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was 
below the epidemic threshold of 7.1% for week 46. 
 
Pneumonia and Influenza Mortality for 122 U.S. Cities 
Week ending 11/20/2010 
4
6
8
10
12
10 20 30 40 50 10 20 30 40 50 10 20 30 40 50 10 20 30 40 50 10 20 30 40
%
 
o
f A
ll D
e
a
th
s 
D
u
e 
to
 
P&
I  
Weeks
Epidemic Threshold
Seasonal Baseline
2007 20082006 2009 2010
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2010-11 Influenza Season – Week 46, ending November 20, 2010           
 
6
 
Influenza-Associated Pediatric Mortality: No influenza-associated pediatric deaths were reported 
to CDC during week 46. 
 
One death, associated with an influenza A virus for which the subtype was not determined, 
occurring during the 2010-2011 season has been reported. 
 
Number of Influenza-Associated Pediatric Deaths by Week of Death: 
2007-08 season to present 
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Week of Death
2007-08
Number of Deaths 
Reported = 88
2008-09
Number of Deaths 
Reported = 133
2009-10
Number of Deaths 
Reported = 282
Deaths Reported Current WeekDeaths Reported Previous Week
2010-11
Number of Deaths 
Reported = 1
 
 
Influenza-Associated Hospitalizations: The Influenza Hospitalization Network (FluSurv-NET) 
conducts surveillance for population-based, laboratory-confirmed influenza related hospitalizations 
in children (persons less than 18 years) and adults. The network covers over 80 counties in the 10 
Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and 
six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates will 
be updated every two weeks starting later this season. 
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Outpatient Illness Surveillance: Nationwide during week 46, 1.4% of patient visits reported 
through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to 
influenza-like illness (ILI). This percentage is below the national baseline of 2.5%. 
 
Percentage of Visits for Influenza-like Illness (ILI) Reported by  
the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), 
Weekly National Summary, September 30, 2007 – November 20, 2010 
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On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 2.7% during 
week 46. All 10 regions reported a proportion of outpatient visits for ILI below their region-specific 
baseline levels.   
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Region 1 - CT, ME, MA, NH, RI, VT
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Region 6 - AR, LA, NM, OK, TX
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Region 2 - NJ, NY, USVI
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Region 3 - DE, DC, MD, PA, VA, WV
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Region 4 - AL, FL, GA, KY, MS, NC, SC, TN
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Region 5 - IL, IN, MI, MN, OH, WI
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Region 7 - IA, KS, MO, NE
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Region 8 - CO, MT, ND, SD, UT, WY
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Region 9 - AZ, CA, HI, NV
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Region 10 - AK, ID, OR, WA
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NOTE: Scales differ between regions
*Use of the regional baselines for state data is not appropriate. 
Baseline*% ILI
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 ILINet Activity Indicator Map: Data collected in ILINet are used to produce a measure of ILI 
activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI 
and are compared to the average percent of ILI visits that occur during spring and fall weeks with 
little or no influenza virus circulation. Activity levels range from minimal, which would correspond to 
ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI 
activity from outpatient clinics being much higher than the average.  Because the clinical definition 
of ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory 
data, the information on ILI activity provides a clear picture of influenza activity in the United States. 
 
During week 46, the following ILI activity levels were experienced: 
 One state (Georgia) experienced high ILI activity.  While influenza-like illness is a non-
specific term and may be caused by a variety of organisms, the increase in ILI in Georgia 
has occurred at the same time as a significant increase in the number of reported influenza 
B virus infections. 
 Two states (Oklahoma and West Virginia) experienced low ILI activity. 
 New York City and 47 states were experiencing minimal ILI activity (Alabama, Alaska, 
Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, 
Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, 
Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, 
New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, 
Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, 
Vermont, Virginia, Washington, Wisconsin, and Wyoming). 
 Data were insufficient to calculate an ILI activity level from the District of Columbia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactive web tool available at: http://gis.cdc.gov/grasp/fluview/main.html 
*This map uses the proportion of outpatient visits to health care providers for influenza-like illness to measure the ILI activity level within a state. It does not, 
however, measure the extent of geographic spread of flu within a state. Therefore, outbreaks occurring in a single city could cause the state to display high 
activity levels. 
Data collected in ILINet may disproportionately represent certain populations within a state, and therefore, may not accurately depict the full picture of 
influenza activity for the whole state. 
Data displayed in this map are based on data collected in ILINet, whereas the State and Territorial flu activity map are based on reports from state and 
territorial epidemiologists. The data presented in this map is preliminary and may change as more data is received. 
Differences in the data presented by CDC and state health departments likely represent differing levels of data completeness with data presented by the 
state likely being the more complete.  
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Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists: The 
influenza activity reported by state and territorial epidemiologists indicates geographic spread of 
influenza viruses, but does not measure the severity of influenza activity. 
 
During week 46, the following influenza activity was reported: 
 Regional influenza activity was reported by one state (Georgia) 
 Local influenza activity was reported by Puerto Rico and seven states (Alabama, Hawaii, 
Mississippi, Oklahoma, Pennsylvania, South Carolina, and Texas). 
 Sporadic influenza activity was reported by the District of Columbia, Guam, the U.S. Virgin 
Islands, and 31 states (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, 
Florida, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, 
Michigan, Minnesota, Missouri, Nevada, New Jersey, New Mexico, New York, North 
Carolina, Ohio, Tennessee, Utah, Virginia, Washington, West Virginia, Wisconsin, and 
Wyoming). 
 No influenza activity was reported by 11 states (Delaware, Iowa, Maine, Montana, 
Nebraska, New Hampshire, North Dakota, Oregon, Rhode Island, South Dakota, and 
Vermont). 
 
 
 
A description of surveillance methods is available at: http://www.cdc.gov/flu/weekly/overview.htm 
Report prepared: November 29, 2010. 
 
 
